392 related articles for article (PubMed ID: 32909178)
1. Repositioning medication for cardiovascular and cerebrovascular disease to delay the onset and prevent progression of Alzheimer's disease.
Lee H; Kim E
Arch Pharm Res; 2020 Sep; 43(9):932-960. PubMed ID: 32909178
[TBL] [Abstract][Full Text] [Related]
2. Antiplatelet activity of drugs used in hypertension, dyslipidemia and diabetes: Additional benefit in cardiovascular diseases prevention.
Sepúlveda C; Palomo I; Fuentes E
Vascul Pharmacol; 2017 Apr; 91():10-17. PubMed ID: 28342822
[TBL] [Abstract][Full Text] [Related]
3. Potential Repositioning of Anti-cancer EGFR Inhibitors in Alzheimer's Disease: Current Perspectives and Challenging Prospects.
Mansour HM; Fawzy HM; El-Khatib AS; Khattab MM
Neuroscience; 2021 Aug; 469():191-196. PubMed ID: 34139302
[TBL] [Abstract][Full Text] [Related]
4. Recent Advances in the Neuroprotective Properties of Ferulic Acid in Alzheimer's Disease: A Narrative Review.
Di Giacomo S; Percaccio E; Gullì M; Romano A; Vitalone A; Mazzanti G; Gaetani S; Di Sotto A
Nutrients; 2022 Sep; 14(18):. PubMed ID: 36145084
[TBL] [Abstract][Full Text] [Related]
5. [Drug Repositioning for Alzheimer's Disease].
Ihara M; Saito S
Brain Nerve; 2019 Sep; 71(9):961-970. PubMed ID: 31506398
[TBL] [Abstract][Full Text] [Related]
6. Scope of new formulation approaches in the repurposing of pioglitazone for the management of Alzheimer's disease.
Jojo GM; Kuppusamy G
J Clin Pharm Ther; 2019 Jun; 44(3):337-348. PubMed ID: 30738020
[TBL] [Abstract][Full Text] [Related]
7. New Drugs from Marine Organisms in Alzheimer's Disease.
Russo P; Kisialiou A; Lamonaca P; Moroni R; Prinzi G; Fini M
Mar Drugs; 2015 Dec; 14(1):5. PubMed ID: 26712769
[TBL] [Abstract][Full Text] [Related]
8. Antidiabetic Drugs in Alzheimer's Disease: Mechanisms of Action and Future Perspectives.
Femminella GD; Bencivenga L; Petraglia L; Visaggi L; Gioia L; Grieco FV; de Lucia C; Komici K; Corbi G; Edison P; Rengo G; Ferrara N
J Diabetes Res; 2017; 2017():7420796. PubMed ID: 28656154
[TBL] [Abstract][Full Text] [Related]
9. Can We Treat Neuroinflammation in Alzheimer's Disease?
Sánchez-Sarasúa S; Fernández-Pérez I; Espinosa-Fernández V; Sánchez-Pérez AM; Ledesma JC
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33228179
[TBL] [Abstract][Full Text] [Related]
10. A review of the mechanisms underlying selected comorbidities in Alzheimer's disease.
Maciejewska K; Czarnecka K; Szymański P
Pharmacol Rep; 2021 Dec; 73(6):1565-1581. PubMed ID: 34121170
[TBL] [Abstract][Full Text] [Related]
11. Cardiac disorders as risk factors for Alzheimer's disease.
de Toledo Ferraz Alves TC; Ferreira LK; Wajngarten M; Busatto GF
J Alzheimers Dis; 2010; 20(3):749-63. PubMed ID: 20413875
[TBL] [Abstract][Full Text] [Related]
12. [Glucagon-like peptide-1 (GLP-1) mimetics: a new treatment for Alzheimer's disease?].
García-Casares N; García-Arnés JA; Gómez-Huelgas R; Valdivielso-Felices P; García-Arias C; González-Santos P
Rev Neurol; 2014 Dec; 59(11):517-24. PubMed ID: 25418147
[TBL] [Abstract][Full Text] [Related]
13. Is a potential Alzheimer's therapy already in use for other conditions? Can medications for hypertension, diabetes and acne help with the symptoms?
Corbett A; Ballard C
Expert Opin Investig Drugs; 2013 Aug; 22(8):941-3. PubMed ID: 23808708
[TBL] [Abstract][Full Text] [Related]
14. New drugs and clinical trials in diabetes and hypertension.
Nilsson P
Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():64-9. PubMed ID: 9288549
[TBL] [Abstract][Full Text] [Related]
15. Mood stabilizers in Alzheimer's disease: symptomatic and neuroprotective rationales.
Tariot PN; Loy R; Ryan JM; Porsteinsson A; Ismail S
Adv Drug Deliv Rev; 2002 Dec; 54(12):1567-77. PubMed ID: 12453674
[TBL] [Abstract][Full Text] [Related]
16. Current therapies and new strategies for the management of Alzheimer's disease.
Aderinwale OG; Ernst HW; Mousa SA
Am J Alzheimers Dis Other Demen; 2010 Aug; 25(5):414-24. PubMed ID: 20601643
[TBL] [Abstract][Full Text] [Related]
17. Drug Repositioning for Alzheimer's Disease: Finding Hidden Clues in Old Drugs.
Ihara M; Saito S
J Alzheimers Dis; 2020; 74(4):1013-1028. PubMed ID: 32144994
[TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapeutic approaches to the prevention of Alzheimer's disease.
Standridge JB
Am J Geriatr Pharmacother; 2004 Jun; 2(2):119-32. PubMed ID: 15555488
[TBL] [Abstract][Full Text] [Related]
19. Drug repositioning approaches for the discovery of new therapeutics for Alzheimer's disease.
Kim TW
Neurotherapeutics; 2015 Jan; 12(1):132-42. PubMed ID: 25549849
[TBL] [Abstract][Full Text] [Related]
20. The Links between Cardiovascular Diseases and Alzheimer's Disease.
Leszek J; Mikhaylenko EV; Belousov DM; Koutsouraki E; Szczechowiak K; Kobusiak-Prokopowicz M; Mysiak A; Diniz BS; Somasundaram SG; Kirkland CE; Aliev G
Curr Neuropharmacol; 2021; 19(2):152-169. PubMed ID: 32727331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
